VIRTUAL SCREENING OF INDONESIAN HERBAL DATABASE TO FIND SIRTUIN 1 ACTIVATORS USING THE DOCKING METHOD
DOI:
https://doi.org/10.22159/ajpcr.2017.v10s5.23121Keywords:
Sirtuin 1 activator, Indonesian natural products, Human degenerative disease, Docking, Grid box, Virtual screeningAbstract
Â
 Objective: Chemical compounds in plants often have benefits and efficacy that can be useful for medicine. Biochemistry and biomedicine research aims to develop new drugs for degenerative human diseases such as cancer, cardiovascular diseases, and diabetes mellitus. Humans have a protein that is the key for metabolic sensors in a variety of metabolic pathways, Sirtuin 1 (SIRT1). Currently, only resveratrol, fisetin, and quercetin, which are compounds from natural ingredients, have been tested as activators of SIRT1 even though there are many chemical compounds in plants that could potentially be SIRT1 activators. Four crystal forms act as SIRT1 activators: 4ZZH, 4ZZI, 4ZZJ, and 5BTR.
Methods: In this study, we employed the docking of new molecular compounds from an Indonesian herbal database as SIRT1 activators. Virtual screening was done using AutoDock Vina. AutoDock Vina was validated beforehand to obtain the best grid box; based on this research, the best grid box for AutoDock Vina is 60 × 60 × 60.
Results: The top 10 ranked compounds were obtained for each crystal form and for the same compounds of the four crystal forms, which are alpha-carotene, Cassiamin C, casuarinin, and lutein.
Downloads
References
Alhazzazi TY, Kamarajan P, Verdin E, Kapila YL. SIRT3 and cancer: Tumor promoter or suppressor? Biochim Biophys Acta 2011;1816(1):80-8.
Dai H, Case AW, Riera TV, Considine T, Lee JE, Hamuro Y, et al. Crystallographic structure of a small molecule SIRT1 activator-enzyme complex. Nat Commun 2015;6(3):7645.
Hubbard BP, Sinclair DA. Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol Sci 2014;35:146-54.
Morris BJ. Seven sirtuins for seven deadly diseases of aging. Free Radic Biol Med 2013;56:133-71.
Frye RA. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 2000;273(2):793-8.
Li X. SIRT1 and energy metabolism. Acta Biochim Biophys Sin (Shanghai) 2013;45(1):51-60.
Haigis MC, Sinclair DA. Mammalian sirtuins: Biological insights and disease relevance. Annu Rev Pathol 2010;5:253-95.
Allard JS, Perez E, Zou S, de Cabo R. Dietary activators of Sirt1. Mol Cell Endocrinol 2009;299(1):58-63.
Baxevanis AD, Ouellette BF. Bioinformatics: A practical guide to the analysis of genes and proteins. Methods of Biochem Analysis. New York: John Wiley & Sons; 2001.
Motiejunas D, Wade RC. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II. New York: Elsevier; 2007.
Leach AR, Shoichet BK, Peishoff CE. Prediction of protein-ligand interactions. Docking and scoring: Successes and gaps. J Med Chem 2006;49(20):5851-5.
Velankar S, Kleywegt GJ. The protein data bank in Europe (PDBe): Bringing structure to biology. Acta Crystallogr D Biol Crystallogr 2011;67:324-30.
DeLano WL. PyMOL’s User’s Guide. San Carlos, CA: DeLano Scientific LLC; 2004. p.66. Available from: http://www.pymol. sourceforge.net/newman/userman.pdf.
Yanuar A, Mun’im A, Lagho AB, Syahdi RR, Rahmat M, Suhartanto H. Medicinal plants database and three-dimensional structure of the chemical compounds from medicinal plants in Indonesia. Int J Comput Sci Issues 2011;8(5):180-3.
Sebastián C, Satterstrom FK, Haigis MC, Mostoslavsky R. From sirtuin biology to human diseases: An update. J Biol Chem 2012;287(51):42444-52.
Hubbard BP, Gomes AP, Dai H, Li J, Case AW, Considine T, et al. Evidence for a common mechanism of SIRT1 regulation by allosteric activators. Science 2013;339(6124):1216-9.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
